These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 30615342)

  • 21. PI3 kinase/AKT pathway as a therapeutic target in multiple myeloma.
    Harvey RD; Lonial S
    Future Oncol; 2007 Dec; 3(6):639-47. PubMed ID: 18041916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway.
    Liang Y; Li X; He X; Qiu X; Jin XL; Zhao XY; Xu RZ
    Eur J Haematol; 2016 Oct; 97(4):371-8. PubMed ID: 26821882
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD138-negative myeloma cells regulate mechanical properties of bone marrow stromal cells through SDF-1/CXCR4/AKT signaling pathway.
    Wu D; Guo X; Su J; Chen R; Berenzon D; Guthold M; Bonin K; Zhao W; Zhou X
    Biochim Biophys Acta; 2015 Feb; 1853(2):338-47. PubMed ID: 25450979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of multiple myeloma cell proliferation by ginsenoside Rg3 via reduction in the secretion of IGF-1.
    Li Y; Yang T; Li J; Hao HL; Wang SY; Yang J; Luo JM
    Mol Med Rep; 2016 Sep; 14(3):2222-30. PubMed ID: 27430248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDK1 promotes the inflammatory progress of fibroblast-like synoviocytes by phosphorylating RSK2.
    Sun C; Sun Y; Jiang D; Bao G; Zhu X; Xu D; Wang Y; Cui Z
    Cell Immunol; 2017 May; 315():27-33. PubMed ID: 28314444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The enhancement of combination of berberine and metformin in inhibition of DNMT1 gene expression through interplay of SP1 and PDPK1.
    Zheng F; Wu J; Tang Q; Xiao Q; Wu W; Hann SS
    J Cell Mol Med; 2018 Jan; 22(1):600-612. PubMed ID: 28840963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.
    Montero JC; López-Pérez R; San Miguel JF; Pandiella A
    Haematologica; 2008 Jun; 93(6):851-9. PubMed ID: 18443272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of B-cell maturation antigen to B-cell activating factor induces survival of multiple myeloma cells by activating Akt and JNK signaling pathways.
    Shen X; Guo Y; Qi J; Shi W; Wu X; Ju S
    Cell Biochem Funct; 2016 Mar; 34(2):104-10. PubMed ID: 26914861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting the mevalonate pathway in multiple myeloma.
    van der Spek E
    Leuk Res; 2010 Mar; 34(3):267-8. PubMed ID: 19695704
    [No Abstract]   [Full Text] [Related]  

  • 30. Targeting the pro-survival protein MET with tivantinib (ARQ 197) inhibits growth of multiple myeloma cells.
    Zaman S; Shentu S; Yang J; He J; Orlowski RZ; Stellrecht CM; Gandhi V
    Neoplasia; 2015 Mar; 17(3):289-300. PubMed ID: 25810013
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined TRAF6 Targeting and Proteasome Blockade Has Anti-myeloma and Anti-Bone Resorptive Effects.
    Chen H; Li M; Sanchez E; Wang CS; Lee T; Soof CM; Casas CE; Cao J; Xie C; Udd KA; DeCorso K; Tang GY; Spektor TM; Berenson JR
    Mol Cancer Res; 2017 May; 15(5):598-609. PubMed ID: 28122920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NF-κB dysregulation in multiple myeloma.
    Matthews GM; de Matos Simoes R; Dhimolea E; Sheffer M; Gandolfi S; Dashevsky O; Sorrell JD; Mitsiades CS
    Semin Cancer Biol; 2016 Aug; 39():68-76. PubMed ID: 27544796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cyproheptadine-induced myeloma cell apoptosis is associated with inhibition of the PI3K/AKT signaling.
    Li J; Cao B; Zhou S; Zhu J; Zhang Z; Hou T; Mao X
    Eur J Haematol; 2013 Dec; 91(6):514-21. PubMed ID: 24033664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of S1P receptor signaling pathway on the survival and drug resistance in multiple myeloma cells.
    Fu D; Li Y; Li J; Shi X; Yang R; Zhong Y; Wang H; Liao A
    Mol Cell Biochem; 2017 Jan; 424(1-2):185-193. PubMed ID: 27785703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway.
    Roy P; Mukherjee T; Chatterjee B; Vijayaragavan B; Banoth B; Basak S
    Oncogene; 2017 Mar; 36(10):1417-1429. PubMed ID: 27641334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial Expression, Purification and In Vitro Phosphorylation of Full-Length Ribosomal S6 Kinase 2 (RSK2).
    Utepbergenov D; Hennig PM; Derewenda U; Artamonov MV; Somlyo AV; Derewenda ZS
    PLoS One; 2016; 11(10):e0164343. PubMed ID: 27732676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitors of the Cyclin-Dependent Kinase and PIM Kinase Pathways in the Treatment of Myeloma.
    Ramakrishnan VG; Kumar SK
    Cancer J; 2016; 22(1):7-11. PubMed ID: 26841010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oligomerized tumor necrosis factor-related apoptosis inducing ligand strongly induces cell death in myeloma cells, but also activates proinflammatory signaling pathways.
    Berg D; Stühmer T; Siegmund D; Müller N; Giner T; Dittrich-Breiholz O; Kracht M; Bargou R; Wajant H
    FEBS J; 2009 Dec; 276(23):6912-27. PubMed ID: 19895579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma.
    Moschetta M; Basile A; Ferrucci A; Frassanito MA; Rao L; Ria R; Solimando AG; Giuliani N; Boccarelli A; Fumarola F; Coluccia M; Rossini B; Ruggieri S; Nico B; Maiorano E; Ribatti D; Roccaro AM; Vacca A
    Clin Cancer Res; 2013 Aug; 19(16):4371-82. PubMed ID: 23804425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular Targeting of ERKs/RSK2 Signaling in Cancers.
    Cho YY
    Curr Pharm Des; 2017 Nov; 23(29):4247-4258. PubMed ID: 28714417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.